Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in agrochemical research for designing new-generation pesticides due to the stability and bioavailability imparted by the trifluoromethoxy group. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.